share_log

Why Moderna Shares Are Falling

Why Moderna Shares Are Falling

为什么摩登那的股价在下跌？
Benzinga Real-time News ·  2021/09/27 14:18

Shares of COVID-19 vaccine makers, including Moderna Inc (NASDAQ:MRNA), are trading lower amid continued volatility in the space as investors weigh booster shot progress. Pfizer CEO Albert Bourla recently predicted a return to 'normal life' within a year with a likely need for annual shots.

新冠肺炎疫苗制造商的股票，包括Moderna(纳斯达克股票代码：mRNA)，由于投资者权衡提振进展，该领域持续波动，股价走低。辉瑞(Pfizer)首席执行官阿尔伯特·布拉(Albert Bourla)最近预测，一年内将恢复“正常生活”，可能需要每年注射一次。

Shares of companies in growth sectors are also trading lower amid a rise in the 10-year treasury yield. The 10-year Treasury yield hit an intraday high of 1.517% Monday morning before dipping to around the 1.484% level. The move in the 10-year note comes after the Federal Reserve last week spoke on winding down its ongoing asset purchasing program.

随着10年期美国国债收益率上升，成长型行业公司的股价也在走低。10年期美国国债收益率周一早盘触及1.517%的盘中高点，之后回落至1.484%左右。在10年期公债走势之前，美联储(Federal Reserve)上周就逐步结束正在进行的资产购买计划发表了讲话。

Moderna is commercial-stage biotech that was founded in 2010. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020.

现代生物技术公司成立于2010年，是一家处于商业阶段的生物技术公司。该公司的信使核糖核酸技术迅速通过了其新冠肺炎疫苗的验证，该疫苗于2020年12月在美国获得授权。

Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease and rare genetic diseases.

截至2021年初，现代有24个mRNA开发项目，其中13个正在进行临床试验。项目涵盖广泛的治疗领域，包括传染病、肿瘤学、心血管疾病和罕见的遗传病。

Moderna has a 52-week high of $497.49 and a 52-week low of $65.49.

摩德纳的52周高点为497.49美元，52周低点为65.49美元。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发